 Connection
Andrew Morris to Plaque, Atherosclerotic
This is a "connection" page, showing publications Andrew Morris has written about Plaque, Atherosclerotic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.836 |
|
|
|
-
Morris AJ, Smyth SS. Lysophosphatidic acid and cardiovascular disease: seeing is believing. J Lipid Res. 2013 May; 54(5):1153-5.
Score: 0.401
-
Li J, Yang L, Song J, Yan B, Morris AJ, Moseley H, Flight R, Wang C, Liu J, Weiss HL, Morris EF, Abdelhamid I, Gerl MJ, Melander O, Smyth S, Evers BM. Neurotensin accelerates atherosclerosis and increases circulating levels of short-chain and saturated triglycerides. Atherosclerosis. 2024 05; 392:117479.
Score: 0.214
-
Reschen ME, Gaulton KJ, Lin D, Soilleux EJ, Morris AJ, Smyth SS, O'Callaghan CA. Lipid-induced epigenomic changes in human macrophages identify a coronary artery disease-associated variant that regulates PPAP2B Expression through Altered C/EBP-beta binding. PLoS Genet. 2015 Apr; 11(4):e1005061.
Score: 0.115
-
Smyth SS, Mueller P, Yang F, Brandon JA, Morris AJ. Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis. Arterioscler Thromb Vasc Biol. 2014 Mar; 34(3):479-86.
Score: 0.106
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|